157 related articles for article (PubMed ID: 34479920)
1. Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Uterine Cervix: Clinicopathological and Molecular Characteristics With Special Emphasis on the First Description of Consistent Programmed Death-ligand 1 (PD-L1) Over-expression.
Choi S; Kim SW; Kim HS
Cancer Genomics Proteomics; 2021; 18(5):685-698. PubMed ID: 34479920
[TBL] [Abstract][Full Text] [Related]
2. Invasive stratified mucin-producing carcinoma (ISMC) of the cervix: a clinicopathological and molecular analysis of 59 cases with special emphasis on histogenesis and potential therapeutic targets.
Yao Y; Wang Y; Ye L; Lu B; Lu W
Histopathology; 2024 Jan; 84(2):315-324. PubMed ID: 37735961
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological features of stratified mucin-producing neoplastic lesions of the cervix].
Xu H; Wang YM; Zhang J
Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):28-33. PubMed ID: 31914531
[No Abstract] [Full Text] [Related]
4. Invasive stratified mucin-producing carcinoma (ISMC) of uterine cervix: description of pathological findings and prognosis factors in a series of 15 Chinese patients.
Lin T; Wang W; Xu L; He Y
Arch Gynecol Obstet; 2022 Nov; 306(5):1703-1709. PubMed ID: 35394200
[TBL] [Abstract][Full Text] [Related]
5. Invasive Stratified Mucin-producing Carcinoma (ISMC) of the Cervix: A Study on Morphologic Diversity.
Stolnicu S; Segura S; Parra-Herran C; Horn LC; Hoang L; Terinte C; Pesci A; Aviel-Ronen S; Kyokawa T; Alvarado-Cabrero I; Oliva E; Soslow RA; Park KJ
Am J Surg Pathol; 2020 Jul; 44(7):873-880. PubMed ID: 32235154
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical and genetic characteristics of HPV-associated endocervical carcinoma with an invasive stratified mucin-producing carcinoma (ISMC) component.
Park E; Kim YT; Kim S; Nam EJ; Cho NH
Mod Pathol; 2021 Sep; 34(9):1738-1749. PubMed ID: 34103667
[TBL] [Abstract][Full Text] [Related]
7. Invasive Stratified Mucinous Carcinoma (iSMC) of the Cervix Often Presents With High-risk Features That Are Determinants of Poor Outcome: An International Multicenter Study.
Stolnicu S; Boros M; Segura S; Horn LC; Parra-Herran C; Oliva E; Abu-Rustum N; Soslow RA; Park KJ
Am J Surg Pathol; 2020 Oct; 44(10):1374-1380. PubMed ID: 32271191
[TBL] [Abstract][Full Text] [Related]
8. Stratified mucin-producing intraepithelial lesion with invasive carcinoma: 12 cases with immunohistochemical and ultrastructural findings.
Onishi J; Sato Y; Sawaguchi A; Yamashita A; Maekawa K; Sameshima H; Asada Y
Hum Pathol; 2016 Sep; 55():174-81. PubMed ID: 27237368
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 Expression and Silva Invasion Pattern in Villoglandular Adenocarcinoma of the Uterine Cervix.
Dietl AK; Beckmann MW; Stuebs FA; Gass P; Emons J; Hartmann A; Erber R
Int J Gynecol Pathol; 2024 Jul; 43(4):397-404. PubMed ID: 38293999
[TBL] [Abstract][Full Text] [Related]
10. Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma.
Yamashita S; Abe H; Kunita A; Yamashita H; Seto Y; Ushiku T
Histopathology; 2021 Feb; 78(3):381-391. PubMed ID: 32767778
[TBL] [Abstract][Full Text] [Related]
11. Association Between Programmed Death-Ligand 1 Expression and Clinicopathological Characteristics, Structural Recurrence, and Biochemical Recurrence/Persistent Disease in Medullary Thyroid Carcinoma.
Shi X; Yu PC; Lei BW; Li CW; Zhang Y; Tan LC; Shi RL; Wang J; Ma B; Xu WB; Wang X; Hu JQ; Huang NS; Wei WJ; Wang Y; Chen TZ; Wang YL; Ji QH
Thyroid; 2019 Sep; 29(9):1269-1278. PubMed ID: 31328653
[No Abstract] [Full Text] [Related]
12. The immune checkpoints CTLA-4 and PD-L1 in carcinomas of the uterine cervix.
Karpathiou G; Chauleur C; Mobarki M; Peoc'h M
Pathol Res Pract; 2020 Jan; 216(1):152782. PubMed ID: 31862202
[TBL] [Abstract][Full Text] [Related]
13. Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expressions in type 2 endometrial cancer.
Kucukgoz Gulec U; Kilic Bagir E; Paydas S; Guzel AB; Gumurdulu D; Vardar MA
Arch Gynecol Obstet; 2019 Aug; 300(2):377-382. PubMed ID: 31076855
[TBL] [Abstract][Full Text] [Related]
14. PD-L1, RB1 and mismatch repair protein immunohistochemical expression in neuroendocrine carcinoma, small cell type, of the uterine cervix.
Morgan S; Slodkowska E; Parra-Herran C; Mirkovic J
Histopathology; 2019 Jun; 74(7):997-1004. PubMed ID: 30667073
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status.
Cha YJ; Kim HR; Lee CY; Cho BC; Shim HS
Lung Cancer; 2016 Jul; 97():73-80. PubMed ID: 27237031
[TBL] [Abstract][Full Text] [Related]
16. Invasive stratified mucin-producing carcinoma (i-SMILE) of the uterine cervix: report of a case series and review of the literature indicating poor prognostic subtype of cervical adenocarcinoma.
Horn LC; Handzel R; Borte G; Siebolts U; Haak A; Brambs CE
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2573-2582. PubMed ID: 31385027
[TBL] [Abstract][Full Text] [Related]
17. Invasive stratified mucin-producing carcinoma: a clinicopathological analysis of three cases.
Lei R
Cancer Biol Ther; 2019; 20(11):1403-1407. PubMed ID: 31362570
[No Abstract] [Full Text] [Related]
18. Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells.
Cruz-Rico G; Avilés-Salas A; Popa-Navarro X; Lara-Mejía L; Catalán R; Sánchez-Reyes R; López-Sánchez D; Cabrera-Miranda L; Aquiles Maldonado-Martínez H; Samtani-Bassarmal S; Arrieta O
Pathol Oncol Res; 2021; 27():597499. PubMed ID: 34257548
[No Abstract] [Full Text] [Related]
19. Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases.
Manson QF; Schrijver WAME; Ter Hoeve ND; Moelans CB; van Diest PJ
Clin Exp Metastasis; 2019 Feb; 36(1):29-37. PubMed ID: 30547271
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma.
Chen K; Cheng G; Zhang F; Zhang N; Li D; Jin J; Wu J; Ying L; Mao W; Su D
Oncotarget; 2016 May; 7(21):30772-80. PubMed ID: 27120796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
